You are here

Hemostatic Agent Development

Award Information
Agency: Department of Defense
Branch: Defense Health Program
Contract: W81XWH-17-C-0184
Agency Tracking Number: H2-0265
Amount: $999,998.00
Phase: Phase II
Program: SBIR
Solicitation Topic Code: N101-085
Solicitation Number: 2010.1
Timeline
Solicitation Year: 2010
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-09-15
Award End Date (Contract End Date): 2020-01-14
Small Business Information
55 W. L. Runnels Industrial Dr., Hattiesburg, MS, 39401
DUNS: 147162866
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Joseph Lichtenhan
 VP Sales & Marketing
 (601) 544-3466
 lichtenhan@hybridplastics.com
Business Contact
 Rusty Clark
Phone: (601) 544-3466
Email: rclark@hybridplastics.com
Research Institution
N/A
Abstract
The proposed effort aims to increase the TRL of the hemostatic agent through completion of relevant animal and toxicological research and development. These advancements will be verified through process improvements to meet good manufacturing practices. A series of registration approvals for the device along with packaging requirements will be advanced. Additional efficacy and competitive performance metrics for the device will be developed and utilized to achieve FDA and DoD approvals.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government